A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants
for Forehead Lines
Sites in New York +4 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07730554·Phase 2·Recruiting·Listed Jul 28, 2026